Antibiotic pharmacodynamics for clinicians

A summary of the basics

Keith Melvin Olsen, Kyle Skiermont, G. Douglas Campbell

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

For an antimicrobial agent to be effective, it must reach the site of infection in sufficient concentration and duration to inhibit pathogen growth. While the minimum inhibitory concentration (MIC) reflects an organism's in vitro susceptibility to an antibiotic, it does not predict drug concentration at the site of infection. Certain classes of antibiotics are more effective in killing pathogens as their peak serum concentration above the MIC is increased (concentration-dependent killing), while others are more effective the longer the antibiotic concentration remains above the pathogen's MIC (time-dependent killing). The fluoroquinolones and aminoglycosides exhibit concentration-dependent killing. Penicillins, carbapenems, cephalosporins, and macrolides - with the exception of azithromycin - display time-dependent killing. In the treatment of pulmonary infections, an antibiotic must cross the blood-bronchoalveolar barrier and enter the epithelial lining fluid. Antibiotics that accomplish this include azithromycin, clarithromycin, and the fluoroquinolones.

Original languageEnglish (US)
Pages (from-to)561-568
Number of pages8
JournalJournal of Respiratory Diseases
Volume23
Issue number11
StatePublished - Nov 1 2002

Fingerprint

Anti-Bacterial Agents
Microbial Sensitivity Tests
Azithromycin
Fluoroquinolones
Infection
Carbapenems
Clarithromycin
Macrolides
Aminoglycosides
Cephalosporins
Anti-Infective Agents
Penicillins
Lung
Growth
Serum
Pharmaceutical Preparations

Keywords

  • AUC/MIC ratios of fluoroquinolones for respiratory pathogens
  • Concentrations of antibiotics in serum and pulmonary tissue
  • Minimum inhibitory concentrations
  • Pharmacodynamic parameters
  • Pharmacodynamic ratios that correspond to antibacterial efficacy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Olsen, K. M., Skiermont, K., & Campbell, G. D. (2002). Antibiotic pharmacodynamics for clinicians: A summary of the basics. Journal of Respiratory Diseases, 23(11), 561-568.

Antibiotic pharmacodynamics for clinicians : A summary of the basics. / Olsen, Keith Melvin; Skiermont, Kyle; Campbell, G. Douglas.

In: Journal of Respiratory Diseases, Vol. 23, No. 11, 01.11.2002, p. 561-568.

Research output: Contribution to journalReview article

Olsen, KM, Skiermont, K & Campbell, GD 2002, 'Antibiotic pharmacodynamics for clinicians: A summary of the basics', Journal of Respiratory Diseases, vol. 23, no. 11, pp. 561-568.
Olsen KM, Skiermont K, Campbell GD. Antibiotic pharmacodynamics for clinicians: A summary of the basics. Journal of Respiratory Diseases. 2002 Nov 1;23(11):561-568.
Olsen, Keith Melvin ; Skiermont, Kyle ; Campbell, G. Douglas. / Antibiotic pharmacodynamics for clinicians : A summary of the basics. In: Journal of Respiratory Diseases. 2002 ; Vol. 23, No. 11. pp. 561-568.
@article{ef4e653581414505babd3f4a772c63c3,
title = "Antibiotic pharmacodynamics for clinicians: A summary of the basics",
abstract = "For an antimicrobial agent to be effective, it must reach the site of infection in sufficient concentration and duration to inhibit pathogen growth. While the minimum inhibitory concentration (MIC) reflects an organism's in vitro susceptibility to an antibiotic, it does not predict drug concentration at the site of infection. Certain classes of antibiotics are more effective in killing pathogens as their peak serum concentration above the MIC is increased (concentration-dependent killing), while others are more effective the longer the antibiotic concentration remains above the pathogen's MIC (time-dependent killing). The fluoroquinolones and aminoglycosides exhibit concentration-dependent killing. Penicillins, carbapenems, cephalosporins, and macrolides - with the exception of azithromycin - display time-dependent killing. In the treatment of pulmonary infections, an antibiotic must cross the blood-bronchoalveolar barrier and enter the epithelial lining fluid. Antibiotics that accomplish this include azithromycin, clarithromycin, and the fluoroquinolones.",
keywords = "AUC/MIC ratios of fluoroquinolones for respiratory pathogens, Concentrations of antibiotics in serum and pulmonary tissue, Minimum inhibitory concentrations, Pharmacodynamic parameters, Pharmacodynamic ratios that correspond to antibacterial efficacy",
author = "Olsen, {Keith Melvin} and Kyle Skiermont and Campbell, {G. Douglas}",
year = "2002",
month = "11",
day = "1",
language = "English (US)",
volume = "23",
pages = "561--568",
journal = "Journal of Respiratory Diseases",
issn = "0194-259X",
number = "11",

}

TY - JOUR

T1 - Antibiotic pharmacodynamics for clinicians

T2 - A summary of the basics

AU - Olsen, Keith Melvin

AU - Skiermont, Kyle

AU - Campbell, G. Douglas

PY - 2002/11/1

Y1 - 2002/11/1

N2 - For an antimicrobial agent to be effective, it must reach the site of infection in sufficient concentration and duration to inhibit pathogen growth. While the minimum inhibitory concentration (MIC) reflects an organism's in vitro susceptibility to an antibiotic, it does not predict drug concentration at the site of infection. Certain classes of antibiotics are more effective in killing pathogens as their peak serum concentration above the MIC is increased (concentration-dependent killing), while others are more effective the longer the antibiotic concentration remains above the pathogen's MIC (time-dependent killing). The fluoroquinolones and aminoglycosides exhibit concentration-dependent killing. Penicillins, carbapenems, cephalosporins, and macrolides - with the exception of azithromycin - display time-dependent killing. In the treatment of pulmonary infections, an antibiotic must cross the blood-bronchoalveolar barrier and enter the epithelial lining fluid. Antibiotics that accomplish this include azithromycin, clarithromycin, and the fluoroquinolones.

AB - For an antimicrobial agent to be effective, it must reach the site of infection in sufficient concentration and duration to inhibit pathogen growth. While the minimum inhibitory concentration (MIC) reflects an organism's in vitro susceptibility to an antibiotic, it does not predict drug concentration at the site of infection. Certain classes of antibiotics are more effective in killing pathogens as their peak serum concentration above the MIC is increased (concentration-dependent killing), while others are more effective the longer the antibiotic concentration remains above the pathogen's MIC (time-dependent killing). The fluoroquinolones and aminoglycosides exhibit concentration-dependent killing. Penicillins, carbapenems, cephalosporins, and macrolides - with the exception of azithromycin - display time-dependent killing. In the treatment of pulmonary infections, an antibiotic must cross the blood-bronchoalveolar barrier and enter the epithelial lining fluid. Antibiotics that accomplish this include azithromycin, clarithromycin, and the fluoroquinolones.

KW - AUC/MIC ratios of fluoroquinolones for respiratory pathogens

KW - Concentrations of antibiotics in serum and pulmonary tissue

KW - Minimum inhibitory concentrations

KW - Pharmacodynamic parameters

KW - Pharmacodynamic ratios that correspond to antibacterial efficacy

UR - http://www.scopus.com/inward/record.url?scp=0036857337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036857337&partnerID=8YFLogxK

M3 - Review article

VL - 23

SP - 561

EP - 568

JO - Journal of Respiratory Diseases

JF - Journal of Respiratory Diseases

SN - 0194-259X

IS - 11

ER -